Amneal Pocfratio from 2010 to 2024

AMRX Stock  USD 8.38  0.01  0.12%   
Amneal Pharmaceuticals, POCF Ratio yearly trend continues to be fairly stable with very little volatility. POCF Ratio will likely drop to 2.94 in 2024. During the period from 2010 to 2024, Amneal Pharmaceuticals, POCF Ratio regression line of annual values had r-squared of  0.05 and arithmetic mean of  58.63. View All Fundamentals
 
POCF Ratio  
First Reported
2010-12-31
Previous Quarter
3.09379826
Current Value
2.94
Quarterly Volatility
94.05253125
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amneal Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 154.9 M, Interest Expense of 119.8 M or Selling General Administrative of 281.2 M, as well as many indicators such as Price To Sales Ratio of 0.42, Dividend Yield of 0.096 or PTB Ratio of 56.75. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals, Valuation or Volatility modules.
  
Check out the analysis of Amneal Pharmaceuticals, Correlation against competitors.

Latest Amneal Pharmaceuticals,'s Pocfratio Growth Pattern

Below is the plot of the Pocfratio of Amneal Pharmaceuticals, Class over the last few years. It is Amneal Pharmaceuticals,'s POCF Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amneal Pharmaceuticals,'s overall financial position and show how it may be relating to other accounts over time.
Pocfratio10 Years Trend
Pretty Stable
   Pocfratio   
       Timeline  

Amneal Pocfratio Regression Statistics

Arithmetic Mean58.63
Geometric Mean18.78
Coefficient Of Variation160.43
Mean Deviation56.71
Median13.23
Standard Deviation94.05
Sample Variance8,846
Range372
R-Value(0.21)
Mean Square Error9,090
R-Squared0.05
Significance0.44
Slope(4.50)
Total Sum of Squares123,842

Amneal Pocfratio History

2024 2.94
2023 3.09
2022 4.61
2021 2.95
2020 1.78
2019 373.41
2018 6.88

About Amneal Pharmaceuticals, Financial Statements

Amneal Pharmaceuticals, investors use historical fundamental indicators, such as Amneal Pharmaceuticals,'s Pocfratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
POCF Ratio 3.09  2.94 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.